152 related articles for article (PubMed ID: 37739233)
41. Quantification of Retinal and Choriocapillaris Perfusion in Different Stages of Macular Telangiectasia Type 2.
Tzaridis S; Wintergerst MWM; Mai C; Heeren TFC; Holz FG; Charbel Issa P; Herrmann P
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3556-3562. PubMed ID: 31415079
[TBL] [Abstract][Full Text] [Related]
42. Demographic features of idiopathic macular telangiectasia in Korean patients.
Kim SH; Oh J; Ahn SE; Park CY; Oh JH
Korean J Ophthalmol; 2015 Jun; 29(3):155-9. PubMed ID: 26028942
[TBL] [Abstract][Full Text] [Related]
43. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
Park YG; Park YH
PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
[TBL] [Abstract][Full Text] [Related]
44. Imaging endpoints for clinical trials in MacTel type 2.
Pauleikhoff D; Pauleikhoff L; Chew EY
Eye (Lond); 2022 Feb; 36(2):284-293. PubMed ID: 34389818
[TBL] [Abstract][Full Text] [Related]
45. Perivenular Capillary Loss: An Early, Quantifiable Change in Macular Telangiectasia Type 2.
Micevych PS; Soetikno BT; Fawzi AA
Transl Vis Sci Technol; 2020 Mar; 9(4):5. PubMed ID: 32818093
[TBL] [Abstract][Full Text] [Related]
46. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.
Srinivasan R; Teussink MM; Sloan KR; Bharat RPK; Narayanan R; Raman R
BMC Ophthalmol; 2022 Jun; 22(1):264. PubMed ID: 35698056
[TBL] [Abstract][Full Text] [Related]
47. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
48. Multicolor imaging in macular telangiectasia-a comparison with fundus autofluorescence.
Govindahari V; Fraser-Bell S; Ayachit AG; Invernizzi A; Nair U; Nair DV; Lupidi M; Singh SR; Rajendran A; Zur D; Gallego-Pinazo R; Marco RD; Cagini C; Cozzi M; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2379-2387. PubMed ID: 32803329
[TBL] [Abstract][Full Text] [Related]
49. Atypical bilateral presentation in idiopathic macular telangiectasia type 1.
Tapia Quijada HE; Mantolan Sarmiento C; Serrano GarcĂa M; Betancor Caro N
Arch Soc Esp Oftalmol (Engl Ed); 2021 Nov; 96(11):602-606. PubMed ID: 34756283
[TBL] [Abstract][Full Text] [Related]
50. Classification of diabetes-related retinal diseases using a deep learning approach in optical coherence tomography.
Perdomo O; Rios H; RodrĂguez FJ; Otálora S; Meriaudeau F; MĂĽller H; González FA
Comput Methods Programs Biomed; 2019 Sep; 178():181-189. PubMed ID: 31416547
[TBL] [Abstract][Full Text] [Related]
51. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
[TBL] [Abstract][Full Text] [Related]
52. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
53. Demographic features of idiopathic macular telangiectasia in Japanese patients.
Maruko I; Iida T; Sugano Y; Ojima A; Oyamada H; Sekiryu T
Jpn J Ophthalmol; 2012 Mar; 56(2):152-8. PubMed ID: 22219035
[TBL] [Abstract][Full Text] [Related]
54. Macular telangiectasia type 2 (MacTel) in a 34-year-old patient.
Nicolai H; Wirix M; Spielberg L; Leys A
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25249218
[TBL] [Abstract][Full Text] [Related]
55. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
56. Relation of interdigitation zone changes and right-angle vessels in Macular Telangiectasia Type-2 (MacTel).
Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S
Eye (Lond); 2023 Oct; 37(14):2977-2986. PubMed ID: 36841866
[TBL] [Abstract][Full Text] [Related]
57. Different types of macular telangiectasia in two eyes of a patient.
Venkatesh R; Reddy NG; Pereira A; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Sep; 32(5):NP9-NP12. PubMed ID: 33960244
[TBL] [Abstract][Full Text] [Related]
58. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
[TBL] [Abstract][Full Text] [Related]
59. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
Lee S; Kim HA; Yoon YH
Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
[TBL] [Abstract][Full Text] [Related]
60. RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2.
Spaide RF; Yannuzzi LA; Maloca PM
Retina; 2018 Oct; 38(10):1920-1929. PubMed ID: 30095711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
